A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Children
NCT00174473 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 49
Last updated 2011-05-10
Summary
This is a study to investigate the pharmacokinetics, safety and tolerability of several doses of voriconazole, intravenous and oral suspension formulations, in children
Conditions
Interventions
- DRUG
-
Voriconazole
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 2 Years
- Max Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-06-30
- Completion
- 2005-08-31
More Related Trials
-
A Study Of The Safety, Tolerability And Effective Of Voriconazole For The Treatment Of Serious Candida Infection And Candida Infection Of The Throat In Pediatric Patients
NCT01092832 ·Status: TERMINATED ·Phase: PHASE3
-
A Pharmacokinetic And Safety Study Of Voriconazole In Healthy Male And Female Adults
NCT00855101 ·Status: COMPLETED ·Phase: PHASE1
-
Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy
NCT00066599 ·Status: COMPLETED ·Phase: PHASE2
-
Voriconazole And Anidulafungin Combination For Invasive Aspergillosis In Pediatric Subjects
NCT01188759 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood.
NCT00163111 ·Status: COMPLETED ·Phase: PHASE3
-
Gastrointestinal Implications of Voriconazole Exposure
NCT02904434 ·Status: WITHDRAWN
-
Development of Voriconazole Pharmacokinetics and Metabolism in Children and Adolescents
NCT01976078 ·Status: COMPLETED
-
An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections
NCT00001757 ·Status: COMPLETED ·Phase: PHASE3
-
A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy Subjects
NCT00940017 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics of Fluconazole in Children (2-18 Years)
NCT05130723 ·Status: UNKNOWN
-
Voriconazole Pharmacokinetics in Children With Gastrointestinal Graft Versus Host Disease
NCT00792246 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal Infections
NCT00647907 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Pharmacokinetics of Intravenous and Oral Posaconazole in Immunocompromised Children (MK-5592-097)
NCT02452034 ·Status: COMPLETED ·Phase: PHASE1
-
Fluconazole Pharmacokinetics in Infants
NCT00514358 ·Status: COMPLETED
-
Study To Assess Pharmacokinetics, Safety & Efficacy of Anidulafungin When Treating Children With Invasive Candidiasis
NCT00761267 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetics of Two Different Formulation of Voriconazole
NCT02912156 ·Status: COMPLETED ·Phase: PHASE4
-
Determination of Voriconazole Levels in Saliva - Validation in Specific Subsets of Patients
NCT01418846 ·Status: COMPLETED
-
Influence of CYP2C19 Genotype on Safety and Efficacy of Voriconazole in Pediatric Patients With Hematologic Malignancy
NCT04743544 ·Status: UNKNOWN
-
An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections
NCT00001810 ·Status: COMPLETED ·Phase: PHASE3
-
Posaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127)
NCT04665037 ·Status: RECRUITING ·Phase: PHASE2
-
To Evaluate the Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of BV100
NCT05684718 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Safety, Tolerance, and Pharmacokinetics of Oral Posaconazole in Immunocompromised Children (P03579)
NCT01716234 ·Status: TERMINATED ·Phase: PHASE1
-
TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects.
NCT00740389 ·Status: COMPLETED ·Phase: PHASE1
-
Posaconazole (MK-5592) Intravenous and Oral in Children With Invasive Aspergillosis (IA) (MK-5592-104)
NCT04218851 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetics of Itraconazole in Pediatric Cancer Patients
NCT01409018 ·Status: COMPLETED ·Phase: PHASE1